Impact of peripheral arterial occlusive disease on the development of contrast medium-induced acute kidney injury

Nephron - Clinical Practice

Volumn 122, Issue 1-2, 2013, Pages 38-43

  Lüders, Florian ^a   Malyar, Nasser ^a   Meyborg, Matthias ^a   Gebauer, Katrin ^a   Brand, Eva ^b   Reinecke, Holger ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Contrast medium induced acute kidney injury; Coronary heart disease; Peripheral arterial occlusive disease

Indexed keywords

CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CONTRAST MEDIUM INDUCED ACUTE KIDNEY FAILURE; DIABETES MELLITUS; DIALYSIS; DRUG INDUCED DISEASE; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL;

ACUTE KIDNEY INJURY; AGED; ARTERIAL OCCLUSIVE DISEASES; CONTRAST MEDIA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES;

EID: 84875665842     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000346105     Document Type: Article

References (19)

1. McCullough PA, Soman SS: Contrast-induced nephropathy. Crit Care Clin 2005; 21: 261-280.
2. Gleeson TG, Bulugahapitiya S: Contrast-induced nephropathy. AJR Am J Roentgenol 2004; 183: 1673-1689.
3. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936.
4. Reinecke H, Fobker M, Wellmann J, et al: A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy. Clin Res Cardiol 2007; 96: 130-139.
5. Rihal CS, Textor SC, Grill DE, et al: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264.
6. Mehran R, Aymong ED, Nikolsky E, et al: A simple risk score for prediction of contrastinduced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399.
7. Bartholomew BA, Harjai KJ, Dukkipati S, et al: Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93: 1515-1519.
8. Krumlovsky FA, Simon N, Santhanam S, et al: Acute renal failure. Association with administration of radiographic contrast material. JAMA 1978; 239: 125-127.
9. Brown JR, Robb JF, Block CA, et al: Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv 2010; 3: 346-350.
10. Marenzi G, Assanelli E, Campodonico J, et al: Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009; 150: 170-177.
11. Tamhane UU, Welch KB, Moscucci M, et al: The relative renal safety of iodixanol compared with low-osmolar contrast media. JACC Cardiovasc Interv 2009; 2: 645-654.
12. Aspelin P, Aubry P, Fransson SG, et al: Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-499.
13. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. Cohort analysis. JAMA 1996; 275: 1489-1494.
14. Guerrero A, Montes R, Muñoz-Terol J, et al: Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant 2006; 21: 3525-3531.
15. Morcos SK, Thomsen HS, European Society of Urogenital Radiology: European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 2003; 28: 187-190.
16. Reinecke H, Trey T, Matzkies F, et al: Grade of chronic renal failure, and acute and longterm outcome after percutaneous coronary interventions. Kidney Int 2003; 63: 696-701.
17. Tepel M, van der Giet M, Schwarzfeld C et al: Prevention of radiographic contrast-agentinduced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184.
18. Lindsay J, Apple S, Pinnow EE, et al: Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 2003; 59: 338-343.
19. Smith SC Jr, Dove JT, Jacobs AK, et al: ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2001; 103: 3019-3041.